Amplified activation of key oncogenic signalling pathways (PI3K/AKT, RAS/MAPK and MYC) upstream of ribosome biogenesis constitutes yet another hallmark of HGSC,nine and we hypothesise that inhibiting ribosome biogenesis can offer a highly effective cancer therapeutic choice.10 In truth, we have shown encouraging responses with the ribosomal RNA gen